FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139368105> ?p ?o ?g. }

• W3139368105 endingPage "764" @default.
• W3139368105 startingPage "759" @default.
• W3139368105 abstract "Background Pazopanib is a tyrosine kinase inhibitor given at the approved dose of 800 mg orally once daily (OD), but often requiring individual dose adjustment due to toxicity. Limited data is available to guide prescription in older patients especially the unfit according to geriatric assessment. Patients and methods VOTRAGE is a 3 + 3 dose-escalation, open-label phase I trial of continuous OD oral administration of pazopanib to evaluate safety, PK and PD data in unfit older patients with advanced solid tumors. The primary objective was to determine the maximum tolerated dose (MTD). PK data were compared with those obtained in younger adult patients in a population PK analysis. Results Eighteen patients with a median age of 82.5 years (range 75–91) were included in three dosing cohorts (400, 600, and 800 mg daily). Three dose-limiting toxicities (DLT) were observed in five patients at 800 mg and one DLT at 600 mg in six evaluable patients. MTD was defined as level 2 dose (600 mg). Individual oral clearance was not correlated with age. A relationship was observed between the occurrence of DLT and pazopanib plasma exposure. Decreased oral bioavailability of pazopanib when given with proton-pump inhibitors was confirmed in this group of patients. Conclusion We recommend performing geriatric assessment in patients older than 75 and starting pazopanib at 600 mg per day in unfit older patients. Therapeutic drug monitoring appears very helpful in this population." @default.
• W3139368105 created "2021-03-29" @default.
• W3139368105 creator A5002046745 @default.
• W3139368105 creator A5003424696 @default.
• W3139368105 creator A5004620976 @default.
• W3139368105 creator A5011506675 @default.
• W3139368105 creator A5012501491 @default.
• W3139368105 creator A5015557556 @default.
• W3139368105 creator A5031969657 @default.
• W3139368105 creator A5031987093 @default.
• W3139368105 creator A5033616609 @default.
• W3139368105 creator A5038098756 @default.
• W3139368105 creator A5040832651 @default.
• W3139368105 creator A5084682660 @default.
• W3139368105 date "2021-06-01" @default.
• W3139368105 modified "2023-09-30" @default.
• W3139368105 title "VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients" @default.
• W3139368105 cites W1544359545 @default.
• W3139368105 cites W1847168837 @default.
• W3139368105 cites W1967974729 @default.
• W3139368105 cites W1976487307 @default.
• W3139368105 cites W1984850666 @default.
• W3139368105 cites W2047871200 @default.
• W3139368105 cites W2052683946 @default.
• W3139368105 cites W2081033553 @default.
• W3139368105 cites W2082755106 @default.
• W3139368105 cites W2086140566 @default.
• W3139368105 cites W2095771928 @default.
• W3139368105 cites W2101776780 @default.
• W3139368105 cites W2116949558 @default.
• W3139368105 cites W2119958965 @default.
• W3139368105 cites W2128529067 @default.
• W3139368105 cites W2162424705 @default.
• W3139368105 cites W2163709153 @default.
• W3139368105 cites W2167333057 @default.
• W3139368105 cites W2290357360 @default.
• W3139368105 cites W2323642978 @default.
• W3139368105 cites W2500897030 @default.
• W3139368105 cites W2513239337 @default.
• W3139368105 cites W2516340525 @default.
• W3139368105 cites W2765595053 @default.
• W3139368105 cites W2792630544 @default.
• W3139368105 cites W2805663073 @default.
• W3139368105 cites W2885052575 @default.
• W3139368105 cites W2912245247 @default.
• W3139368105 cites W2946285920 @default.
• W3139368105 cites W2981546775 @default.
• W3139368105 cites W2991525471 @default.
• W3139368105 doi "https://doi.org/10.1016/j.jgo.2021.02.006" @default.
• W3139368105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33715996" @default.
• W3139368105 hasPublicationYear "2021" @default.
• W3139368105 type Work @default.
• W3139368105 sameAs 3139368105 @default.
• W3139368105 citedByCount "5" @default.
• W3139368105 countsByYear W31393681052020 @default.
• W3139368105 countsByYear W31393681052021 @default.
• W3139368105 countsByYear W31393681052022 @default.
• W3139368105 countsByYear W31393681052023 @default.
• W3139368105 crossrefType "journal-article" @default.
• W3139368105 hasAuthorship W3139368105A5002046745 @default.
• W3139368105 hasAuthorship W3139368105A5003424696 @default.
• W3139368105 hasAuthorship W3139368105A5004620976 @default.
• W3139368105 hasAuthorship W3139368105A5011506675 @default.
• W3139368105 hasAuthorship W3139368105A5012501491 @default.
• W3139368105 hasAuthorship W3139368105A5015557556 @default.
• W3139368105 hasAuthorship W3139368105A5031969657 @default.
• W3139368105 hasAuthorship W3139368105A5031987093 @default.
• W3139368105 hasAuthorship W3139368105A5033616609 @default.
• W3139368105 hasAuthorship W3139368105A5038098756 @default.
• W3139368105 hasAuthorship W3139368105A5040832651 @default.
• W3139368105 hasAuthorship W3139368105A5084682660 @default.
• W3139368105 hasConcept C112705442 @default.
• W3139368105 hasConcept C121608353 @default.
• W3139368105 hasConcept C126322002 @default.
• W3139368105 hasConcept C126894567 @default.
• W3139368105 hasConcept C143998085 @default.
• W3139368105 hasConcept C181389837 @default.
• W3139368105 hasConcept C2426938 @default.
• W3139368105 hasConcept C2777288759 @default.
• W3139368105 hasConcept C2778439243 @default.
• W3139368105 hasConcept C2778820342 @default.
• W3139368105 hasConcept C2779490328 @default.
• W3139368105 hasConcept C2908647359 @default.
• W3139368105 hasConcept C29730261 @default.
• W3139368105 hasConcept C71924100 @default.
• W3139368105 hasConcept C98274493 @default.
• W3139368105 hasConcept C99454951 @default.
• W3139368105 hasConceptScore W3139368105C112705442 @default.
• W3139368105 hasConceptScore W3139368105C121608353 @default.
• W3139368105 hasConceptScore W3139368105C126322002 @default.
• W3139368105 hasConceptScore W3139368105C126894567 @default.
• W3139368105 hasConceptScore W3139368105C143998085 @default.
• W3139368105 hasConceptScore W3139368105C181389837 @default.
• W3139368105 hasConceptScore W3139368105C2426938 @default.
• W3139368105 hasConceptScore W3139368105C2777288759 @default.
• W3139368105 hasConceptScore W3139368105C2778439243 @default.
• W3139368105 hasConceptScore W3139368105C2778820342 @default.
• W3139368105 hasConceptScore W3139368105C2779490328 @default.

• next